Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 770

Results For "ENT"

9376 News Found

Molbio Diagnostics’ Truenat platform deployed to diagonise TB in India
News | March 24, 2022

Molbio Diagnostics’ Truenat platform deployed to diagonise TB in India

This drive will expand access to quality diagnostics and help find the ‘missing millions’ – patients that are suffering from TB but not registered in the healthcare system


Seven ways the pharma industry can benefit from tech-driven logistics solutions
Opinion | March 24, 2022

Seven ways the pharma industry can benefit from tech-driven logistics solutions

The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable


USFDA approves Novartis Pluvicto to treat prostrate cancer
Drug Approval | March 24, 2022

USFDA approves Novartis Pluvicto to treat prostrate cancer

USFDA also approved complementary diagnostic imaging agent, Locametz, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions


Carestream Health India launch Lux 35 detector
Medical Device | March 24, 2022

Carestream Health India launch Lux 35 detector

The new glass-free detector has improved durability, is more reliable, and has an improved rugged design to sustain in a high workload environment


Kiran Mazumdar-Shaw elected as the Fellow of Royal Society of Edinburgh
News | March 24, 2022

Kiran Mazumdar-Shaw elected as the Fellow of Royal Society of Edinburgh

Kiran will be joining RSE's current Fellowship of around 1,700 Fellows who are recognized as being some of the greatest thinkers, researchers and practitioners working in or with Scotland


Insilico Medicine and EQRx to jointly advance AI-driven drug discovery
Biotech | March 24, 2022

Insilico Medicine and EQRx to jointly advance AI-driven drug discovery

The collaboration leverages Insilico's end-to-end AI-driven Pharma.AI platform to discover novel small molecule drug candidates for multiple targets, along with EQRx's innovative business model to accelerate drug development and patient access to novel medicines at affordable prices


SRL Diagnostics launches whole genome sequencing test for Tuberculosis
Clinical Trials | March 24, 2022

SRL Diagnostics launches whole genome sequencing test for Tuberculosis

The test can overcome the time and cost limitations of traditional culture-based drug susceptibility testing as it can more rapidly detect all mutations known to be associated with drug resistance for any TB drug in one step


HaystackAnalytics sees alarming rise in TB cases
Healthcare | March 24, 2022

HaystackAnalytics sees alarming rise in TB cases

A staggering 65% of the TB cases in India are in the 15-45 age group


Clinical Trials in the New Normal
Opinion | March 24, 2022

Clinical Trials in the New Normal

The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay


Johnson & Johnson India launches ‘Be The Change For TB’ initiative
Public Health | March 24, 2022

Johnson & Johnson India launches ‘Be The Change For TB’ initiative

#BeTheChangeForTB is a public awareness initiative under the Corporate TB Pledge and aims to create a cadre of Youth Changemakers who can act as catalysts of change to help eliminate TB from India